Fundraising FoxMicroPure Genomics
San Diego, US · Delaware corporation
Find your way into MicroPure Genomics
Sign up to see every warm intro you have to MicroPure Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MicroPure Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RM
RM
Ryan MontesNamed on SEC filing
JB
Jason ButlerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$675K disclosed across 1 round · 2026
▶$675KraisedJul 2026 · 11 investors · BiotechnologyRule 506(b)
▶$675KraisedJul 2026 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ryan MontesExecutive Officer, Director
- Jason ButlerExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $675K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Polaris GenomicsPolaris Genomics is a Veteran-owned biotech startup mapping molecular biomarkers to develop objective, biologically-based diagnostics and novel therapeutics for mental health and neuropsychiatric conditions such as PTSD. It combines genomics and AI to advance precision mental health care.
Orbit GenomicsOrbit Genomics is a precision healthcare company built on OrbiSeq, an AI-enabled genomics platform that analyzes short tandem repeats (STRs) alongside single nucleotide polymorphisms to detect disease biology. Its lead product is a blood test for diagnosing early-stage lung cancer in patients with indeterminate pulmonary nodules, with a pipeline extending across other therapeutic areas.
Phase GenomicsPhase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Genomics PlcGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
Companies working in the same space as MicroPure Genomics.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2023 | $274.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded MicroPure Genomics?
- MicroPure Genomics was founded by Ryan Montes, Ph.D..
- How much funding has MicroPure Genomics raised?
- MicroPure Genomics has disclosed $675K raised across 1 round.
- Where is MicroPure Genomics headquartered?
- MicroPure Genomics is headquartered in San Diego, US.